Drug Trial Radar · NCT04697641
Helicobacter Pylori Eradication in Functional Dyspepsia
Last checked: Nov 19, 2026Latest source record: Jan 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
202
Actual
Start
Sep 1, 2017
Primary completion
May 31, 2019
Study completion May 31, 2019
Sponsor
- Lead sponsor
- Sir Ganga Ram HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 6, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to study benefit of eradicating Helicobacter Pylori in patients with functional dyspepsia as compared to symptomatic treatment only. Helicobacter pylori positive patients with Functional Dyspepsia will be divided into two study groups, one will receive Helicobacter pylori eradication therapy and other will receive symptomatic treatment. Symptom relief based on Likert scale will be compared in both groups.
Conditions
- Dyspepsia
- Helicobacter Pylori Infection
Interventions
Clarithromycin 500mgDrug
Clarithromycin 500 mg twice a day for two weeks
Amoxicillin 1000 MGDrug
Amoxicillin 1000mg twice a day for two weeks
Pantoprazole 40mgDrug
Pantoprazole 40 mg or equivalent for eight weeks
LevosulpirideDrug
Levosulpiride 25 mg as and when required before meals
AcotiamideDrug
Acotiamide 100mg as when required before meals
ItoprideDrug
Itopride 50mg as when required before meals
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment SuccessTime frame: Six months after the completion of intervention
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital
New Delhi, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.